Objective:
To assess diabetic retinopathy (DR) as determined by lesions identified using mydriatic ultrawide field imaging (DiSLO200; Optos plc, Scotland, UK) compared with Early Treatment Diabetic Retinopathy Study (ETDRS) 7-standard field film photography.
Design:
Prospective comparative study of DiSLO200, ETDRS 7-standard field film photographs, and dilated fundus examination (DFE).
Participants:
A total of 206 eyes of 103 diabetic patients selected to represent all levels of DR.
Methods:
Subjects had DiSLO200, ETDRS 7-standard field film photographs, and DFE. Images were graded for severity and distribution of DR lesions. Discrepancies were adjudicated, and images were compared side by side.
Main Outcome Measures:
Distribution of hemorrhage and/or microaneurysm (H/Ma), venous beading (VB), intraretinal microvascular abnormality (IRMA), and new vessels elsewhere (NVE). Kappa (κ) and weighted κ statistics for agreement.
Results:
The distribution of DR severity by ETDRS 7-standard field film photographs was no DR 12.5%; nonproliferative DR mild 22.5%, moderate 30%, and severe/very severe 8%; and proliferative DR 27%. Diabetic retinopathy severity between DiSLO200 and ETDRS film photographs matched in 80% of eyes (weighted κ = 0.74,κ = 0.84) and was within 1 level in 94.5% of eyes. DiSLO200 and DFE matched in 58.8% of eyes (weighted κ = 0.69,κ = 0.47) and were within 1 level in 91.2% of eyes. Forty eyes (20%) had DR severity discrepancies between DiSLO200 and ETDRS film photographs. The retinal lesions causing discrepancies were H/Ma 52%, IRMA 26%, NVE 17%, and VB 4%. Approximately one-third of H/Ma, IRMA, and NVE were predominantly outside ETDRS fields. Lesions identified on DiSLO200 but not ETDRS film photographs suggested a more severe DR level in 10% of eyes. Distribution in the temporal, superotemporal, inferotemporal, superonasal, and inferonasal fields was 77%, 72%, 61%, 65%, and 59% for H/Ma, respectively (P<0.0001); 22%, 24%, 21%, 28%, and 22% for VB, respectively (P = 0.009); 52%, 40%, 29%, 47%, and 36% for IRMA, respectively (P<0.0001), and 8%, 4%, 4%, 8%, and 5% for NVE, respectively (P = 0.03). All lesions were more frequent in the temporal fields compared with the nasal fields (P<0.0001).
Conclusions:
DiSLO200 images had substantial agreement with ETDRS film photographs and DFE in determining DR severity. On the basis of DiSLO200 images, significant nonuniform distribution of DR lesions was evident across the retina. The additional peripheral lesions identified by DiSLO200 in this cohort suggested a more severe assessment of DR in 10% of eyes than was suggested by the lesions within the ETDRS fields. However, the implications of peripheral lesions on DR progression within a specific ETDRS severity level over time are unknown and need to be evaluated prospectively.
Citing Articles
Utilizing fundus images captured by two ultra-wide field imaging systems to measure diagnostic indicators and assess the grade of diabetic retinopathy.
Sun Y, Chen X, Song Z, Liu T, Tao Y, Lai T
BMC Ophthalmol. 2025; 25(1):72.
PMID: 39930419
PMC: 11812173.
DOI: 10.1186/s12886-024-03835-6.
Quantitative ultra-widefield fluorescein angiography biomarkers in diabetic retinopathy and association with treatment and progression.
Iyengar R, Fleifil S, Aaberg M, Yu G, Patel T, Powell C
Clin Ophthalmol. 2025; 18:4019-4028.
PMID: 39741795
PMC: 11687090.
DOI: 10.2147/OPTH.S472071.
Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study.
Marques I, Reste-Ferreira D, Santos T, Mendes L, Martinho A, Yamaguchi T
Ophthalmol Sci. 2024; 5(2):100632.
PMID: 39639890
PMC: 11616502.
DOI: 10.1016/j.xops.2024.100632.
Intraretinal Microvascular Abnormalities in Eyes with Advanced Stages of Nonproliferative Diabetic Retinopathy: Comparison Between UWF-FFA, CFP, and OCTA-The RICHARD Study.
Santos A, Lopes M, Santos T, Reste-Ferreira D, Marques I, Yamaguchi T
Ophthalmol Ther. 2024; 13(12):3161-3173.
PMID: 39460896
PMC: 11564449.
DOI: 10.1007/s40123-024-01054-2.
ETDRS grading with CLARUS ultra-widefield images shows agreement with 7-fields colour fundus photography.
Santos A, Ghate S, Lopes M, Rocha A, Santos T, Reste-Ferreira D
BMC Ophthalmol. 2024; 24(1):387.
PMID: 39227901
PMC: 11369991.
DOI: 10.1186/s12886-024-03537-z.
RELIABILITY OF CLINICAL GRADING OF DIABETIC RETINOPATHY COMPARED WITH GRADING OF ULTRA-WIDEFIELD IMAGES.
Castellanos-Canales D, Decker N, Fukuyama H, Duffy B, Fawzi A
Retina. 2024; 44(8):1279-1287.
PMID: 39047122
PMC: 11279382.
DOI: 10.1097/IAE.0000000000004140.
Quantitative Biomarkers of Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography.
Fleifil S, Azzouz L, Yu G, Powell C, Bommakanti N, Paulus Y
Clin Ophthalmol. 2024; 18:1961-1970.
PMID: 39005586
PMC: 11244066.
DOI: 10.2147/OPTH.S462223.
Peripheral retinal lesions in diabetic retinopathy on ultra-widefield imaging.
Ashrafkhorasani M, Habibi A, Nittala M, Corradetti G, Emamverdi M, Sadda S
Saudi J Ophthalmol. 2024; 38(2):123-131.
PMID: 38988777
PMC: 11232752.
DOI: 10.4103/sjopt.sjopt_151_23.
Cross-modality transfer learning with knowledge infusion for diabetic retinopathy grading.
Chen T, Bai Y, Mao H, Liu S, Xu K, Xiong Z
Front Med (Lausanne). 2024; 11:1400137.
PMID: 38808141
PMC: 11130363.
DOI: 10.3389/fmed.2024.1400137.
Relationship between macular perfusion and lesion distribution in diabetic retinopathy.
Manafi N, Oncel D, Verma A, Corradetti G, Kadomoto S, Mahmoudi A
Eye (Lond). 2024; 38(14):2724-2730.
PMID: 38724702
PMC: 11427675.
DOI: 10.1038/s41433-024-03105-1.
Visualizing features with wide-field volumetric OCT angiography.
Hormel T, Liang G, Wei X, Guo Y, Gao M, Wang J
Opt Express. 2024; 32(6):10329-10347.
PMID: 38571248
PMC: 11018334.
DOI: 10.1364/OE.510640.
Controllable editing via diffusion inversion on ultra-widefield fluorescein angiography for the comprehensive analysis of diabetic retinopathy.
Ma X, Ji Z, Chen Q, Ge L, Wang X, Chen C
Biomed Opt Express. 2024; 15(3):1831-1846.
PMID: 38495723
PMC: 10942674.
DOI: 10.1364/BOE.517819.
Assessing Diabetic Retinopathy Staging With AI: A Comparative Analysis Between Pseudocolor and LED Imaging.
Cicinelli M, Gravina S, Rutigliani C, Checchin L, La Franca L, Lattanzio R
Transl Vis Sci Technol. 2024; 13(3):11.
PMID: 38488432
PMC: 10946690.
DOI: 10.1167/tvst.13.3.11.
Retinal non-perfusion: recognizing and defining what is important.
Cao J, Al-Khersan H, Chaudhary V, Wykoff C
Eye (Lond). 2024; 38(9):1608-1609.
PMID: 38438795
PMC: 11156853.
DOI: 10.1038/s41433-024-02981-x.
Macula vs periphery in diabetic retinopathy: OCT-angiography and ultrawide field fluorescein angiography imaging of retinal non perfusion.
Vujosevic S, Fantaguzzi F, Silva P, Salongcay R, Brambilla M, Torti E
Eye (Lond). 2024; 38(9):1668-1673.
PMID: 38402286
PMC: 11156842.
DOI: 10.1038/s41433-024-02989-3.
Assessment of area and structural irregularity of retinal layers in diabetic retinopathy using machine learning and image processing techniques.
Riazi-Esfahani H, Jafari B, Azimi H, Rahimi M, Saeidian J, Pouya P
Sci Rep. 2024; 14(1):4013.
PMID: 38369610
PMC: 10874958.
DOI: 10.1038/s41598-024-54535-6.
Programmatically Localizing Diabetic Retinopathy Features in 45-Degree Retinal Photographs Using Anatomical Colocation.
Murphy T, Douglass A, van Wijngaarden P, Armitage J
J Clin Med. 2024; 13(3).
PMID: 38337501
PMC: 10856732.
DOI: 10.3390/jcm13030807.
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System.
Tan T, Jampol L, Ferris F, Tadayoni R, Sadda S, Chong V
Ophthalmol Sci. 2024; 4(3):100449.
PMID: 38313399
PMC: 10837643.
DOI: 10.1016/j.xops.2023.100449.
Present and future screening programs for diabetic retinopathy: a narrative review.
Taha A, Dinesen S, Vergmann A, Grauslund J
Int J Retina Vitreous. 2024; 10(1):14.
PMID: 38310265
PMC: 10838429.
DOI: 10.1186/s40942-024-00534-8.
Wide-field imaging with smartphone based fundus camera: grading of severity of diabetic retinopathy and locating peripheral lesions in diabetic retinopathy.
Rajalakshmi R, Mohammed R, Vengatesan K, PramodKumar T, Venkatesan U, Usha M
Eye (Lond). 2024; 38(8):1471-1476.
PMID: 38297154
PMC: 11126401.
DOI: 10.1038/s41433-024-02928-2.